Pea Muffins for Blood Sugar and Appetite Control
(PEA3 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is part of a group of studies whose overall goal is to accurately define the physiochemical and structural effects of pea varieties and relate these to blood glucose attenuation and appetite related sensations in healthy human volunteers.
Who Is on the Research Team?
Heather Blewett, PhD
Principal Investigator
Agriculture and Agri-Food Canada
Are You a Good Fit for This Trial?
Healthy men and women aged 18-40, with a BMI of 18.5-30, who eat three meals daily can join this study on peas in muffins affecting blood sugar and fullness. Excluded are those with diabetes, abnormal cholesterol or triglycerides, recent major surgery, liver/kidney disease, cancer treatment within a year, shift workers, unstable weight or dieting individuals.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants attend 4 clinic visits in a fasted state to consume muffins with and without peas and provide various samples and questionnaires
Follow-up
Participants are monitored for gastrointestinal side effects and calorie intake post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Split Pea Muffins
- Wheat Muffins
- Whole Pea Muffins
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Boniface Hospital
Lead Sponsor
University of Manitoba
Collaborator
Agriculture and Agri-Food Canada
Collaborator